3-Ethyl-2-(3-phenylpropyl)-6-pyridin-4-ylpyrimidin-4-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 3-Ethyl-2-(3-phenylpropyl)-6-pyridin-4-ylpyrimidin-4-one
• 化学式: C₂₀H₂₁N₃O
• 分子量: 319.406
• InChiKey: QDNFMHNLJPBGRK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  45.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  异烟酰乙酸乙酯 在 sodium hydride 、 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 3-Ethyl-2-(3-phenylpropyl)-6-pyridin-4-ylpyrimidin-4-one
  参考文献：
  名称：

  6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors

  摘要：

  The discovery of a series of 6-(4-pyridyl)pyrimidin-4(3H)-ones derived from a hit compound with low molecular weight and sufficient chemical space is reported. Transformation of substituents led to subnanomolar potent inhibitors with in vivo tau phoshorylation lowering activity. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.09.021

文献信息

• [EN] 3-SUBSTITUTED-4-PYRIMIDONE DERIVATIVES<br/>[FR] DERIVES 4-PYRIMIDONE 3-SUBSTITUES
  申请人：MITSUBISHI TOKYO PHARM INC

  公开号：WO2001070683A2

  公开（公告）日：2001-09-27

  3-Substituted-4-pyrimidone derivatives represented by formula (I) or salts thereof, solvates thereof or hydrates thereof, wherein R1 represents a C¿1?-C18 alkyl group which may be substituted or a C6-C14 aryl group which may be substituted; R?2¿ represents a C¿1?-C18 alkyl group which may be substituted or a C7-C20 aralkyl group which may be substituted; and a medicament comprising said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as neurodegenerative diseases (e.g. Alzheimer disease) and the like.